TITLE

Use of host factors to identify people at high risk for cutaneous malignant melanoma

AUTHOR(S)
Marrett, Loraine D.; King, Will D.; Walter, Stephen D.; From, Lynn
PUB. DATE
August 1992
SOURCE
CMAJ: Canadian Medical Association Journal;8/15/1992, Vol. 147 Issue 4, p445
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35469656

 

Related Articles

  • Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Elwood, J.M.; Gallagher, R.P.; Hill, G.B.; Spinelli, J.J.; Pearson, J.C.G.; Threlfall, W. // British Medical Journal (Clinical Research Edition);1/14/1984, Vol. 288 Issue 6411, p99 

    Examines the risk factors affecting cutaneous melanoma. Increase in the mortality rates of malignant melanoma around the world; Citation of skin pigmentation as one of the variables connected to the disease; Similarity of results with the study using population-based control.

  • Broad-Spectrum Sunscreen Use and the Development of New Nevi in White Children. Gallagher, Richard P.; Rivers, Jason K.; Lee, Tim K.; Bajdik, Chris D.; McLean, David I.; Coldman, Andrew J. // JAMA: Journal of the American Medical Association;6/14/2000, Vol. 283 Issue 22, p2955 

    Reports on a study that determines whether the use of broad-spectrum, high-sun protection factor (SPF) sunscreen attenuates the development of nevi in white children. Risk factor for cutaneous malignant melanoma found in high nevus density; Study conducted on school children in British...

  • Evidence for the Role of Blue Light in the Development of Uveal Melanoma. Logan, Patrick; Bernabeu, Miguel; Ferreira, Alberto; Burnier, Miguel N. // Journal of Ophthalmology;5/17/2015, Vol. 2015, p1 

    Uveal melanoma is the most common malignancy of the adult eye. Although it is a relatively infrequent tumor, clinical prognosis is often poor owing to a high incidence of aggressive metastatic disease, for which there are limited treatment options. Little is known about the etiology of this...

  • The Management of High-Risk Melanoma: Staging, Treatment, and Nursing Issues. Noel, Sue; Strohl, Roberta // Dermatology Nursing;Dec2002, Vol. 14 Issue 6, p363 

    Discusses the management of high risk melanoma. Stage classifications of malignant melanoma (MM); Ptient compliance to adjuvant therapy; Information on the American Joint Committee on Cancer Staging System for cutaneous melanoma; Role of nurses in caring for patients with MM.

  • The Rising Incidence of Melanoma in Children And Adolescents. Hoang, Minh-Tuan Richard; Eichenfield, Lawrence F. // Dermatology Nursing;Jun2000, Vol. 12 Issue 3, p188 

    Discusses the increasing incidence of malignant melanoma in children and adolescents. Controversy regarding the use of sunscreens for preventing malignant melanomas; Risk factors; Prognosis in children.

  • Associations between environmental factors and incidence of cutaneous melanoma. Review. Volkovova, Katarina; Bilanicova, Dagmar; Bartonova, Alena; Letašiová, Silvia; Dusinska, Maria // Environmental Health: A Global Access Science Source;2012, Vol. 11 Issue Suppl 1, p1 

    Background: Cutaneous melanoma is one of the most serious skin cancers. It is caused by neural crest-derived melanocytes - pigmented cells normally present in the epidermis and, sometimes, in the dermis. Methods: We performed a review of current knowledge on the risk factors of cutaneous...

  • Linkage Analysis of Extended High-Risk Pedigrees Replicates a Cutaneous Malignant Melanoma Predisposition Locus on Chromosome 9q21. Cannon-Albright, Lisa A; Teerlink, Craig C; Farnham, James M; Thomas, Alun W; Zone, John J; Leachman, Sancy A // Journal of Investigative Dermatology;Jan2013, Vol. 133 Issue 1, p128 

    Three predisposition genes have been identified for cutaneous malignant melanoma (CMM), but they account for only ∼25% of melanoma clusters/pedigrees. Linkage analyses of melanoma pedigrees from many countries have failed to identify significant linkage evidence for the remaining...

  • Acquired Dysplastic Melanocytic Nevi and Cutaneous Melanoma: Precursors and Prevention. Rhodes, Arthur R. // Annals of Internal Medicine;Apr85, Vol. 102 Issue 4, p546 

    Editorial. Discusses research on acquired dysplastic melanocytic nevi and cutaneous melanoma. Characteristics of people at risk for cutaneous melanoma; Description of acquired dysplastic nevi; Magnitude of the melanoma risk in familial cutaneous melanoma.

  • Benign melanocytic naevi as a risk factor for malignant melanoma. Swerdlow, A.J.; English, J.; MacKie, R.M.; O'Doherty, C.J.; Hunter, J.A.A.; Clark, J.; Hole, D.J. // British Medical Journal (Clinical Research Edition);6/14/1986, Vol. 292 Issue 6535, p1555 

    Evaluates benign melanocytic naevi as a risk factor for malignant melanoma. Formation of high risk melanocytes; Suggestions on people with large numbers of benign melanocytic naevi; Investigation of aetiology of benign melanocytic naevi.

  • Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis. Markovic, Svetomir N.; Erickson, Lori A.; Rao, Ravi D.; Weenig, Roger H.; Pockaj, Barbara A.; Bardia, Aditya; Vachon, Celine M.; Schild, Steven E.; McWilliams, Robert R.; Hand, Jennifer L.; Laman, Susan D.; Kottschade, Lisa A.; Maples, William J.; Pittelkow, Mark R.; Pulido, Jose S.; Cameron, J. Douglas; Creagan, Edward T. // Mayo Clinic Proceedings;Mar2007, Vol. 82 Issue 3, p364 

    Malignant melanoma is an aggressive, therapy-resistant malignancy of melanocytes. The incidence of melanoma has been steadily Increasing worldwide, resulting in an increasing public health problem. Exposure to solar UV radiation, fair skin, dysplastic nevi syndrome, and a family history of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics